Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3,810.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,100.00
  • 52 Week Low: 2,750.00
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 2,132
  • Market Cap: £195.94m
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
25.62% above the market average25.62% above the market average25.62% above the market average25.62% above the market average25.62% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
1yr Revenue Growth
10.44% above the market average10.44% above the market average10.44% above the market average10.44% above the market average10.44% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
64.86% below the market average64.86% below the market average64.86% below the market average64.86% below the market average64.86% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
1yr DPS Growth
58.38% above the market average58.38% above the market average58.38% above the market average58.38% above the market average58.38% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
59.65% above the market average59.65% above the market average59.65% above the market average59.65% above the market average59.65% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Price Book Ratio
95.92% below the market average95.92% below the market average95.92% below the market average95.92% below the market average95.92% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
10.15% above the market average10.15% above the market average10.15% above the market average10.15% above the market average10.15% above the market average
45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average45.76% above the sector average
Price Chg 3m
45.79% above the market average45.79% above the market average45.79% above the market average45.79% above the market average45.79% above the market average
35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average35.59% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
14.22% above the market average14.22% above the market average14.22% above the market average14.22% above the market average14.22% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Momentum 20
75.29% above the market average75.29% above the market average75.29% above the market average75.29% above the market average75.29% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
77.86% above the market average77.86% above the market average77.86% above the market average77.86% above the market average77.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
74.47% above the market average74.47% above the market average74.47% above the market average74.47% above the market average74.47% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
89.45% above the market average89.45% above the market average89.45% above the market average89.45% above the market average89.45% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
40.97% below the market average40.97% below the market average40.97% below the market average40.97% below the market average40.97% below the market average
15% below the sector average15% below the sector average15% below the sector average15% below the sector average15% below the sector average
Operating Profit Loss
18.10% above the market average18.10% above the market average18.10% above the market average18.10% above the market average18.10% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
26.85% below the market average26.85% below the market average26.85% below the market average26.85% below the market average26.85% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Cash
7.35% below the market average7.35% below the market average7.35% below the market average7.35% below the market average7.35% below the market average
8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,810.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,100.00
52 Week Low 2,750.00
Volume 2,132
Shares Issued 5.14m
Market Cap £195.94m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.47% below the market average83.47% below the market average83.47% below the market average83.47% below the market average83.47% below the market average
93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average
Price Trend
61.68% above the market average61.68% above the market average61.68% above the market average61.68% above the market average61.68% above the market average
52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average52.54% above the sector average
Income
30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Growth
45.81% above the market average45.81% above the market average45.81% above the market average45.81% above the market average45.81% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 11-Apr-19 25-Oct-18
Paid 26-Apr-19 09-Nov-18
Amount 30.00p 36.00p

Trades for 19-Sep-2019

Time Volume / Share Price
16:03 317 @ 3,777.62p
14:41 310 @ 3,780.00p
13:00 91 @ 3,780.00p
10:51 150 @ 3,780.00p
10:49 250 @ 3,822.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page